Sign in

CIK 0001082554

  • Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
521984749
Phone
+1 301-608-9292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$344,206,005
in 74 filings, $343.4M under 10b5-1 plans

Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-11-10 BENKOWITZ MICHAEL PRESIDENT AND COO Sale 10b5-1 −7,875 $452.04 $3.6M 0
2025-11-10 BENKOWITZ MICHAEL PRESIDENT AND COO Exercise or conversion · Stock Options 10b5-1 −14,625 26,625
2025-11-10 BENKOWITZ MICHAEL PRESIDENT AND COO Exercise or conversion · Stock Options 10b5-1 −7,875 2,625
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Exercise or conversion 10b5-1 +21,000 $146.03 $3.1M 29,118
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −1,052 $446.51 $470K 28,066
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −1,539 $447.47 $689K 26,527
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −3,356 $448.33 $1.5M 23,171
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −653 $449.00 $293K 22,518
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −600 $450.80 $270K 21,918
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −1,065 $451.87 $481K 20,853
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −2,170 $452.76 $982K 18,683
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −4,633 $453.81 $2.1M 14,050
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −3,342 $454.82 $1.5M 10,708
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −2,590 $455.83 $1.2M 8,118
2025-11-10 EDGEMOND JAMES CFO AND TREASURER Exercise or conversion · Stock Option 10b5-1 −21,000 10,312
2025-11-10 ROTHBLATT MARTINE A Chairperson & CEO Exercise or conversion 10b5-1 +4,000 $120.26 $481K 4,130
2025-11-10 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −3,500 $448.27 $1.6M 630
2025-11-10 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −500 $449.22 $225K 130
2025-11-10 ROTHBLATT MARTINE A Chairperson & CEO Exercise or conversion · Stock Option 10b5-1 −4,000 110,000
2025-11-07 ROTHBLATT MARTINE A Chairperson & CEO Exercise or conversion 10b5-1 +4,000 $120.26 $481K 4,130

Page 184 of 214 · 4,273 trades